Skip to main content
Zentalis Pharmaceuticals, Inc. (ZNTL)
NASDAQ: ZNTL · Real-Time Price · USD
2.480
+0.185 (8.06%)
At close: Mar 9, 2026, 4:00 PM EDT
2.490
+0.010 (0.40%)
After-hours: Mar 9, 2026, 5:56 PM EDT

Zentalis Pharmaceuticals Revenue

Zentalis Pharmaceuticals had revenue of $26.87M in the twelve months ending September 30, 2025, down -33.76% year-over-year. In the year 2024, Zentalis Pharmaceuticals had annual revenue of $67.43M.

Revenue (ttm)
$26.87M
Revenue Growth
-33.76%
P/S Ratio
5.98
Revenue / Employee
$161,837
Employees
166
Market Cap
160.58M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202467.43M--
Dec 31, 2023---
Dec 31, 2022---
Dec 31, 2021---
Dec 31, 2020---
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
MacroGenics 127.63M
Sangamo Therapeutics 32.88M
Innate Pharma 14.84M
Fate Therapeutics 6.65M
Rani Therapeutics Holdings 1.20M
Connect Biopharma Holdings 762.00K
Artiva Biotherapeutics 251.00K
Revenue Rankings

ZNTL News

More News